Changes in Body Composition When Ingesting a Dairy Compound Enriched With Leucine
NCT ID: NCT04345237
Last Updated: 2020-05-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
142 participants
INTERVENTIONAL
2019-11-15
2020-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Leucine on Body Composition and Muscle Characteristics in Elderly, Type 2 Diabetes Patients
NCT00643773
Leucine Supplementation in Elderly Men
NCT00807508
Whey Protein Supplementation Associated With Resistance Training on Health Indicators in Trained Older Women
NCT03247192
Effect of Whey Protein Supplementation and Resistance Exercise on Muscle Parameters in Older Adults
NCT00635739
The Effect of Nutritional Interventions on Exercise-induced Muscle Damage
NCT02839525
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental group 1 (TS + placebo)
Training twice a week, with wave periodization. Traditional training (TS) in two circuits. Each exercise is separated by a rest period of 3 minutes and 5 minutes between circuits.
Daily consumption for 3 months of placebo milk.
dietary supplement consumption
Consumption of the product under study for 3 months, milk placebo or experimental product (leucine milk).
In addition, 5 of the arms perform physical activity training
Experimental group 2 (TS + leucine)
Training twice a week, with wave periodization. Traditional training (TS) in two circuits. Each exercise is separated by a rest period of 3 minutes and 5 minutes between circuits.
Daily consumption for 3 months of milk enriched with leucine.
dietary supplement consumption
Consumption of the product under study for 3 months, milk placebo or experimental product (leucine milk).
In addition, 5 of the arms perform physical activity training
Experimental group 3 (HRC + placebo)
Training twice a week, with wave periodization. High intensity training (HRC) on two circuits. Each exercise is separated by a rest period of 35 seconds and 5 minutes between circuits.
Daily consumption for 3 months of placebo milk.
dietary supplement consumption
Consumption of the product under study for 3 months, milk placebo or experimental product (leucine milk).
In addition, 5 of the arms perform physical activity training
Experimental group 4 (HRC + leucine)
Training twice a week, with wave periodization. High intensity training (HRC) on two circuits. Each exercise is separated by a rest period of 35 seconds and 5 minutes between circuits.
Daily consumption for 3 months of milk enriched with leucine.
dietary supplement consumption
Consumption of the product under study for 3 months, milk placebo or experimental product (leucine milk).
In addition, 5 of the arms perform physical activity training
Experimental group 5 (no physical exercise + leucine)
The subjects will not carry out any type of physical activity.
Daily consumption for 3 months of milk enriched with leucine.
dietary supplement consumption
Consumption of the product under study for 3 months, milk placebo or experimental product (leucine milk).
In addition, 5 of the arms perform physical activity training
Control (no physical exercise + placebo)
The subjects will not carry out any type of physical activity.
Daily consumption for 3 months of placebo milk.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
dietary supplement consumption
Consumption of the product under study for 3 months, milk placebo or experimental product (leucine milk).
In addition, 5 of the arms perform physical activity training
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body mass index less than 35.
* Subjects who have given written informed consent to participate in the study.
Exclusion Criteria
* Presence of absolute or relative contraindications ruled by the American College of Sports Medicine (ACSM, 1995), during the performance of stress tests.
* Presence of chronic diseases that prevent the performance of a physical exercise program or an exercise test (disabling arthropathies, moderate / severe chronic lung diseases, ischemic heart disease under treatment, arrhythmias, etc).
* Abuse in the ingestion of alcohol.
* Present hypersensitivity or intolerance to any of the components of the products under study.
* Inability to understand informed consent.
55 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad Católica San Antonio de Murcia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Francisco Javier López Román
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Catholic University of Murcia
Murcia, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UCAMCFE-00013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.